Evidence map›Paper›PMID 30082586›Full record

ArticleBioengineering (Basel, Switzerland)2018

Host Response and Neo-Tissue Development during Resorption of a Fast Degrading Supramolecular Electrospun Arterial Scaffold.

Renee Duijvelshoff, Nicole C A van Engeland, Karen M R Gabriels, Serge H M Söntjens, Anthal I P M Smits, Patricia Y W Dankers, Carlijn V C Bouten

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Marker-Independent Monitoring ofFrontiers in cardiovascular medicine · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Renee DuijvelshoffDepartment of Biomedical Engineering, Eindhoven University of Technology, 5600 MB Eindhoven, The Netherlands. r.duijvelshoff@tue.nl.
Nicole C A van EngelandDepartment of Biomedical Engineering, Eindhoven University of Technology, 5600 MB Eindhoven, The Netherlands. N.C.A.v.Engeland@tue.nl.ORCID 0000-0002-7883-3163
Karen M R GabrielsDepartment of Biomedical Engineering, Eindhoven University of Technology, 5600 MB Eindhoven, The Netherlands. karen.gabriels@outlook.com.
Serge H M SöntjensSyMO-Chem B.V., 5600 MB Eindhoven, The Netherlands. S.Sontjens@tue.nl.ORCID 0000-0001-5939-6925
Anthal I P M SmitsDepartment of Biomedical Engineering, Eindhoven University of Technology, 5600 MB Eindhoven, The Netherlands. A.I.P.M.Smits@tue.nl.
Patricia Y W DankersDepartment of Biomedical Engineering, Eindhoven University of Technology, 5600 MB Eindhoven, The Netherlands. P.Y.W.Dankers@tue.nl.
Carlijn V C BoutenDepartment of Biomedical Engineering, Eindhoven University of Technology, 5600 MB Eindhoven, The Netherlands. C.V.C.Bouten@tue.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In situ vascular tissue engineering aims to regenerate vessels "at the target site" using synthetic scaffolds that are capable of inducing endogenous regeneration. Critical to the success of this approach is a fine balance between functional neo-tissue formation and scaffold degradation. Circulating immune cells are important regulators of this process as they drive the host response to the scaffold and they play a central role in scaffold resorption. Despite the progress made with synthetic scaffolds, little is known about the host response and neo-tissue development during and after scaffold resorption. In this study, we designed a fast-degrading biodegradable supramolecular scaffold for arterial applications and evaluated this development in vivo. Bisurea-modified polycaprolactone (PCL2000-U4U) was electrospun in tubular scaffolds and shielded by non-degradable expanded polytetrafluoroethylene in order to restrict transmural and transanastomotic cell ingrowth. In addition, this shield prevented graft failure, permitting the study of neo-tissue and host response development after degradation. Scaffolds were implanted in 60 healthy male Lewis rats as an interposition graft into the abdominal aorta and explanted at different time points up to 56 days after implantation to monitor sequential cell infiltration, differentiation, and tissue formation in the scaffold. Endogenous tissue formation started with an acute immune response, followed by a dominant presence of pro-inflammatory macrophages during the first 28 days. Next, a shift towards tissue-producing cells was observed, with a striking increase in α-Smooth Muscle Actin-positive cells and extracellular matrix by day 56. At that time, the scaffold was resorbed and immune markers were low. These results suggest that neo-tissue formation was still in progress, while the host response became quiescent, favoring a regenerative tissue outcome. Future studies should confirm long-term tissue homeostasis, but require the strengthening of the supramolecular scaffold if a non-shielded model will be used.

Indexed as

biomaterialshost responsemacrophagetissue engineeringvascular graft

Identifiers

PMID30082586
PMCPMC6164451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.